Research
Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c6046 (Published 24 November 2010) Cite this as: BMJ 2010;341:c6046Related articles
- Editorial Published: 24 November 2010; BMJ 341 doi:10.1136/bmj.c5891
- Clinical Review Published: 31 March 2011; BMJ 342 doi:10.1136/bmj.d1938
- Letter Published: 19 January 2011; BMJ 342 doi:10.1136/bmj.d306
- Analysis Published: 18 October 2007; BMJ 335 doi:10.1136/bmj.39335.541782.AD
See more
- StatinsBMJ January 24, 2024, 384 e072584; DOI: https://doi.org/10.1136/bmj-2022-072584
- Proton pump inhibitorsBMJ November 13, 2023, 383 e070752; DOI: https://doi.org/10.1136/bmj-2022-070752
- Recognition and initial management of ovarian torsionBMJ April 28, 2023, 381 e074514; DOI: https://doi.org/10.1136/bmj-2022-074514
- Aortic stenosisBMJ March 15, 2023, 380 e070511; DOI: https://doi.org/10.1136/bmj-2022-070511
- Human monkeypox: diagnosis and managementBMJ February 06, 2023, 380 e073352; DOI: https://doi.org/10.1136/bmj-2022-073352
Cited by...
- Characteristics, temporal trends, and outcomes of intravenous thrombolysis in stroke patients aged > 80 years in China
- Outcomes of endovascular thrombectomy in the elderly: a 'real-world multicenter study
- Thrombectomy for acute ischemic stroke in the elderly: a 'real world experience
- Outcome after stroke thrombolysis in patients >80 years treated within 3 hours vs >3-4.5 hours
- The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
- Why are acute ischemic stroke patients not receiving IV tPA?: Results from a national registry
- Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients >=90 Years of Age
- Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Changes in European Label and Guideline Adherence After Updated Recommendations for Stroke Thrombolysis: Results From the Safe Implementation of Treatments in Stroke Registry
- Predicting Functional Outcome and Symptomatic Intracranial Hemorrhage in Patients With Acute Ischemic Stroke: A Glimpse Into the Crystal Ball?
- Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial
- Influence of Age on Clinical and Revascularization Outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry
- Thrombolysis in Experimental Cerebral Amyloid Angiopathy and the Risk of Secondary Intracerebral Hemorrhage
- Baseline National Institutes of Health Stroke Scale-Adjusted Time Window for Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke
- A Case-Controlled Comparison of Thrombolysis Outcomes Between Wake-Up and Known Time of Onset Ischemic Stroke Patients
- Contraindications to intravenous rtPA for acute stroke: A critical reappraisal
- A novel clinical and imaging based score for predicting outcome prior to endovascular treatment of acute ischemic stroke
- Thrombolysis in Stroke Despite Contraindications or Warnings?
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100
- Impact of Acute Ischemic Stroke Treatment in Patients >80 Years of Age: The Specialized Program of Translational Research in Acute Stroke (SPOTRIAS) Consortium Experience
- Impact of Atrial Fibrillation on Outcome in Thrombolyzed Patients With Stroke: Evidence From the Virtual International Stroke Trials Archive (VISTA)
- In Anticipation of International Stroke Trial-3 (IST-3)
- Interventional Stroke Therapies in the Elderly: Are We Helping?
- Improved Prediction of Poor Outcome After Thrombolysis Using Conservative Definitions of Symptomatic Hemorrhage
- Low-Dose Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy for Patients With Stroke Outside European Indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry
- Challenging the validity of imposing contraindications to thrombolysis for acute ischemic stroke
- Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus
- Letter by Scheitz et al Regarding Article, "Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke"
- Thrombolysis improves 90-day functional outcome in acute ischaemic stroke, even in very older people
- Are all IV thrombolysis exclusion criteria necessary?: Being SMART about evidence-based medicine
- Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase
- Observational data insufficient to change treatment
- Authors' reply
- Age and Outcomes with Thrombolysis for Acute Ischemic Stroke
- Intravenous thrombolysis for stroke